obesity drug news today glp-1 october 2025 Alarming rise in weight loss overdoses Alarming rise in weight loss

If the motion is approved, people who are diagnosed with non-arteritic anterior ischemic optic neuropathy (NAION) after taking Mounjaro will be able to benefit from the consolidations made in a group litigation

The same study found that 66% of those taking tirzepatide lost 10% or more of their initial weight, while only 41.1% of the semaglutide group did

The Amgen team has chosen a less traveled path

Addiction treatment centers are already prescribing GLP-1 medicines to patients While clinical trials continue, some major addiction treatment facilities, or at least one, arent waiting for the final verdict on GLP-1 medications

Cooper, M

Han, Y., et al